Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

about

Bioanalytical methods for the determination of itraconazole and hydroxyitraconazole: overview from clinical pharmacology, pharmacokinetic, pharmacodynamic and metabolism perspectives.Effect of erythromycin and rifampicin on monoethylglycinexylidide test.

P2860

Q33421192-61D0056E-1E50-4630-9AE0-14EAFD6C84BD Q42142006-AA8D875F-06D9-4643-949B-EF579C511731

P2860

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

Item

http://www.wikidata.org/entity/Q45077738

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@en

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@nl

type

Item

label

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@en

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@nl

prefLabel

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@en

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@nl

P1476

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

@en

P2093

Klaus T Olkkola

http://www.w3.org/2001/XMLSchema#string

Mika H Isohanni

http://www.w3.org/2001/XMLSchema#string

Pertti J Neuvonen

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and localization of CYP3A4 and CYP3A5 in human lung

Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function

Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.

Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine.

Simultaneous determination of lidocaine, bupivacaine, and their two main metabolites using gas chromatography and a nitrogen-phosphorus detector: selection of stationary phase and chromatographic conditions.

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

P304

120-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-7843.2004.950303.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8266974

http://www.w3.org/2001/XMLSchema#string

P698

15447735

http://www.w3.org/2001/XMLSchema#string

P921

lidocaine

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

about

P2860

P2860

Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921